Formulation, Characterization and Physicochemical Evaluation of Potassium Citrate Effervescent Tablets

被引:31
作者
Aslani, Abolfazl
Fattahi, Fatemeh
机构
[1] Isfahan Univ Med Sci, Sch Pharm, Dept Pharmaceut, Esfahan, Iran
[2] Isfahan Univ Med Sci, Novel Drug Delivery Syst Res Ctr, Esfahan, Iran
关键词
Effervescent tablets; Potassium citrate; Direct compression method; Fusion method; Wet granulation method;
D O I
10.5681/apb.2013.036
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
Purpose: The aim of this study was to design and formulation of potassium citrate effervescent tablet for reduction of calcium oxalate and urate kidney stones in patients suffering from kidney stones. Methods: In this study, 13 formulations were prepared from potassium citrate and effervescent base in different concentration. The flowability of powders and granules was studied. Then effervescent tablets were prepared by direct compression, fusion and wet granulation methods. The prepared tablets were evaluated for hardness, friability, effervescent time, pH, content uniformity. To amend taste of formulations, different flavoring agents were used and then panel test was done by using Latin Square method by 30 volunteers. Results: Formulations obtained from direct compression and fusion methods had good flow but low hardness. Wet granulation improves flowability and other physicochemical properties such as acceptable hardness, effervescence time <= 3 minutes, pH<6, friability <1%, water percentage < 0.5% and accurate content uniformity. In panel test, both of combination flavors; (orange - lemon) and (strawberry - raspberry) had good acceptability. Conclusion: The prepared tablets by wet granulation method using PVP solution had more tablet hardness. It is a reproducible process and suitable to produce granules that are compressed into effervescent tablets due to larger agglomerates.
引用
收藏
页码:217 / 225
页数:9
相关论文
共 18 条
[1]
Agrawal R, 2011, INT J PHARM FRONT RE, V1, P65
[2]
Bioavailability of a new effervescent tablet of ibuprofen in healthy volunteers [J].
Altomare, E ;
Vendemiale, G ;
Benvenuti, C ;
Andreatta, P .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (06) :505-506
[3]
Amela J, 2000, J PHARM BELY, V55, P53
[4]
Ansel HC., 2010, ANSELS PHARM DOSAGE
[5]
Aulton ME, 2002, SCI DOSAGE FORM DESI
[6]
Brich GG, 1981, SWEETNESS SWEETNERS
[7]
EQUILIBRIUM MOISTURE-CONTENT OF PHARMACEUTICAL EXCIPIENTS [J].
CALLAHAN, JC ;
CLEARY, GW ;
ELEFANT, M ;
KAPLAN, G ;
KENSLER, T ;
NASH, RA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1982, 8 (03) :355-369
[8]
Lachman L, 1986, THEORY PRACTICE IND, V18, P480
[9]
Lewis G.A., 2002, ENCY PHARM TECHNOLOG, V2nd, P1922
[10]
MCEVOY G, 2005, AHFS DRUG INFORM